共 50 条
- [22] Effects of fulvestrant in premenopausal women with oestrogen receptor-positive primary breast cancer EJC SUPPLEMENTS, 2004, 2 (03): : 73 - 74
- [27] Estrogen receptor-negative/progesterone receptor-positive and her-2-negative breast cancer might no longer be classified as hormone receptor-positive breast cancer International Journal of Clinical Oncology, 2022, 27 : 1145 - 1153